Clinical Trial Update: Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes

View source ↗

Summary

This update summarizes a completed clinical trial evaluating prandial-oriented biphasic insulin aspart 30 as a premixed insulin therapy for adults with type 2 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• insulin aspart 30 premixed (biphasic) (insulin aspart 30)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED